Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly
A Multi-center, Randomized, Open-label, Phase IV Study to Investigate the Management of Pasireotide-induced Hyperglycemia With Incretin Based Therapy or Insulin in Adult Patients With Cushing's Disease or Acromegaly
Sponsor: Novartis Pharmaceuticals
A PHASE4 clinical study on Acromegaly and Cushing's Disease, this trial is completed. The trial is conducted by Novartis Pharmaceuticals and has accumulated 15 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
15 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE4
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2019 — Jan 2021 [monthly]
Completed PHASE4
▶ Show 10 earlier versions
-
Feb 2019 — Jun 2019 [monthly]
Completed PHASE4
-
Dec 2018 — Feb 2019 [monthly]
Completed PHASE4
-
Nov 2018 — Dec 2018 [monthly]
Completed PHASE4
-
Aug 2018 — Nov 2018 [monthly]
Completed PHASE4
Status: Recruiting → Completed
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE4
-
Oct 2017 — Jun 2018 [monthly]
Recruiting PHASE4
-
Jul 2017 — Oct 2017 [monthly]
Recruiting PHASE4
-
Apr 2017 — Jul 2017 [monthly]
Recruiting PHASE4
-
Feb 2017 — Apr 2017 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
May 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Novartis Pharmaceuticals
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aalborg, Denmark , Aarhus, Denmark , Altunizade, Turkey (Türkiye) , Ankara, Turkey (Türkiye) , Antalya, Turkey (Türkiye) , Bangalore, India , Bangkok, Thailand , Beijing, China , Chengdu, China , Chesapeake, United States and 30 more locations